Literature DB >> 22074626

On how Rac controls hematopoietic stem cell activity.

J A Cancelas1.   

Abstract

Rac GTPases form part of the family of Rho small GTPases. Rac GTPases, like other Rho family GTPases, are key molecular switches controlling the transduction of external signals to cytoplasmic and nuclear effectors. The development of genetic and pharmacological tools has allowed a more precise definition of the specific roles of Rac GTPases in hematopoietic stem cells (HSCs). Our current knowledge has enabled dissection of their specific and redundant roles. Rac GTPases are now known to be crucial in the response of HSCs to the hematopoietic microenvironment cues. This review will briefly summarize the known HSC functions that are regulated by Rac GTPases, focusing on adhesion, migration, retention, proliferation, and survival, and how Rac relates to the physiological functions of HSC. The development of small molecule inhibitors with the ability to interfere with Rac GTPase activation offers new therapeutic strategies to manipulate the function of HSC in vivo and ex vivo.
© 2011 American Association of Blood Banks.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22074626      PMCID: PMC3308685          DOI: 10.1111/j.1537-2995.2011.03378.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  55 in total

Review 1.  Kit signal transduction.

Authors:  M L Taylor; D D Metcalfe
Journal:  Hematol Oncol Clin North Am       Date:  2000-06       Impact factor: 3.722

Review 2.  The whys and hows of hematopoietic progenitor and stem cell mobilization.

Authors:  A Kessinger; J G Sharp
Journal:  Bone Marrow Transplant       Date:  2003-03       Impact factor: 5.483

Review 3.  Rho signalling at a glance.

Authors:  Martin Schwartz
Journal:  J Cell Sci       Date:  2004-11-01       Impact factor: 5.285

4.  A member of the ras gene superfamily is expressed specifically in T, B and myeloid hemopoietic cells.

Authors:  N V Shirsat; R J Pignolo; B L Kreider; G Rovera
Journal:  Oncogene       Date:  1990-05       Impact factor: 9.867

5.  Feasibility of ESHAP + G-CSF as peripheral blood hematopoietic progenitor cell mobilisation regimen in resistant and relapsed lymphoma: a single-center study of 22 patients.

Authors:  J Petit; C Boqué; J A Cancelas; J Sarrà; J Muñoz; J Garcia; A Grañena
Journal:  Leuk Lymphoma       Date:  1999-06

6.  rac, a novel ras-related family of proteins that are botulinum toxin substrates.

Authors:  J Didsbury; R F Weber; G M Bokoch; T Evans; R Snyderman
Journal:  J Biol Chem       Date:  1989-10-05       Impact factor: 5.157

Review 7.  Circulating stem cells and tissue repair.

Authors:  B Hennessy; M Körbling; Z Estrov
Journal:  Panminerva Med       Date:  2004-03       Impact factor: 5.197

8.  Genetic evidence for convergence of c-Kit- and alpha4 integrin-mediated signals on class IA PI-3kinase and the Rac pathway in regulating integrin-directed migration in mast cells.

Authors:  Bai Lin Tan; Mustafa N Yazicioglu; David Ingram; Jennifer McCarthy; Jovencio Borneo; David A Williams; Reuben Kapur
Journal:  Blood       Date:  2003-01-30       Impact factor: 22.113

9.  Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts.

Authors:  Charles E Murry; Mark H Soonpaa; Hans Reinecke; Hidehiro Nakajima; Hisako O Nakajima; Michael Rubart; Kishore B S Pasumarthi; Jitka Ismail Virag; Stephen H Bartelmez; Veronica Poppa; Gillian Bradford; Joshua D Dowell; David A Williams; Loren J Field
Journal:  Nature       Date:  2004-03-21       Impact factor: 49.962

10.  Cross-talk between RhoH and Rac1 in regulation of actin cytoskeleton and chemotaxis of hematopoietic progenitor cells.

Authors:  Hee-Don Chae; Katherine E Lee; David A Williams; Yi Gu
Journal:  Blood       Date:  2007-12-18       Impact factor: 22.113

View more
  7 in total

1.  Pak2 regulates hematopoietic progenitor cell proliferation, survival, and differentiation.

Authors:  Yi Zeng; Hal E Broxmeyer; Karl Staser; Brahmananda Reddy Chitteti; Su-Jung Park; Seongmin Hahn; Scott Cooper; Zejin Sun; Li Jiang; XianLin Yang; Jin Yuan; Rachelle Kosoff; George Sandusky; Edward F Srour; Jonathan Chernoff; D Wade Clapp
Journal:  Stem Cells       Date:  2015-05       Impact factor: 6.277

2.  The gp130 Cytokine Interleukin-11 Regulates Engraftment of Vav1-/- Hematopoietic Stem and Progenitor Cells in Lethally Irradiated Recipients.

Authors:  Serena De Vita; Yanhua Li; Chad E Harris; Meaghan K McGuinness; Clement Ma; David A Williams
Journal:  Stem Cells       Date:  2018-01-10       Impact factor: 6.277

3.  Mitochondrial Dysfunction in Human Leukemic Stem/Progenitor Cells upon Loss of RAC2.

Authors:  Marta E Capala; Henny Maat; Francesco Bonardi; Vincent van den Boom; Jeroen Kuipers; Edo Vellenga; Ben N G Giepmans; Jan Jacob Schuringa
Journal:  PLoS One       Date:  2015-05-27       Impact factor: 3.240

4.  Pharmacological Rac1 inhibitors with selective apoptotic activity in human acute leukemic cell lines.

Authors:  Natalia Fernández; Pablo Lorenzano Menna; Maia Cabrera; Emiliana Echeverria; Federico Remes Lenicov; Georgina Cardama; Nazareno Gonzalez; Carlos Davio
Journal:  Oncotarget       Date:  2017-10-04

5.  Small G protein Rac GTPases regulate the maintenance of glioblastoma stem-like cells in vitro and in vivo.

Authors:  Yun-Ju Lai; Jui-Cheng Tsai; Ying-Ting Tseng; Meng-Shih Wu; Wen-Shan Liu; Hoi-Ian Lam; Jei-Hwa Yu; Susan E Nozell; Etty N Benveniste
Journal:  Oncotarget       Date:  2017-03-14

6.  RAC2 acts as a prognostic biomarker and promotes the progression of clear cell renal cell carcinoma.

Authors:  Yuenan Liu; Gong Cheng; Zhengshuai Song; Tianbo Xu; Hailong Ruan; Qi Cao; Keshan Wang; Lin Bao; Jingchong Liu; Lijie Zhou; Di Liu; Hongmei Yang; Ke Chen; Xiaoping Zhang
Journal:  Int J Oncol       Date:  2019-07-26       Impact factor: 5.650

7.  ADP-Ribosylation Factor Like GTPase 4C (ARL4C) augments stem-like traits of glioblastoma cells by upregulating ALDH1A3.

Authors:  Qian Chen; Wen-Juan Fu; Xiao-Peng Tang; Lu Wang; Qin Niu; Shuai Wang; Yong Lin; Mian-Fu Cao; Rong Hu; Hai-Yan Wen; Yan Wang; Xia Zhang; Xiao-Hong Yao
Journal:  J Cancer       Date:  2021-01-01       Impact factor: 4.207

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.